Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Temperature Control in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Temperature Control in Bioreactor Operations – V 2.0


Standard Operating Procedure for Temperature Control in Bioreactor Operations for Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/068/2025
Supersedes SOP/BS/068/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for controlling, monitoring, and documenting temperature parameters in bioreactors used for upstream biosimilar manufacturing to ensure optimal cell culture conditions and regulatory compliance.

2. Scope

This SOP applies to all stainless steel and single-use bioreactors (1L to 2000L capacity) operated in the upstream process areas for biosimilar production at [Insert Facility Name].

3. Responsibilities

  • Upstream Operator: Monitors temperature, verifies alarms, and records observations in logs.
  • Engineering Team: Calibrates sensors and maintains heating/cooling jackets and control systems.
  • QA Officer: Reviews temperature trends and verifies compliance with validated ranges.

4. Accountability

The Head of Bioprocess Operations is accountable for ensuring adherence to temperature control procedures and reporting any deviations or equipment malfunctions.

5. Procedure

5.1 Pre-Operation Verification

  1. Ensure bioreactor temperature sensor is calibrated within the last 6 months (Annexure-1).
  2. Verify setpoint and deadband settings as per batch record: typically 36.5°C–37.5°C.
  3. Confirm that the control unit (PID controller or PLC) is operational and shows no prior faults.

5.2 Temperature Setpoint Configuration

  1. Set temperature on the bioreactor control panel as per process requirement (e.g., 37.0°C).
  2. Input control parameters (P, I, D values) based on system tuning documentation.
  3. Start temperature control loop, allowing jacket fluid to circulate.

5.3 Monitoring During Operation

  1. Monitor bioreactor display panel for live temperature and jacket temperature every 2 hours.
  2. Record actual temperature in the Bioreactor Monitoring Log (Annexure-2).
  3. If deviation > ±0.5°C from setpoint, initiate deviation handling (SOP/BS/050/2025).

5.4 Alarm Response and Troubleshooting

  1. In case of temperature alarm:
    • Verify probe immersion and function.
    • Check jacket chiller or heating system for blockages or leaks.
    • Escalate unresolved issues to maintenance.

5.5 Post-Run Shutdown

  1. Turn off temperature control loop.
  2. Inspect and clean jacket circulation system if required.
  3. Document final reading and post-run status in Annexure-3.

6. Abbreviations

  • PID: Proportional-Integral-Derivative
  • PLC: Programmable Logic Controller
  • QA: Quality Assurance

7. Documents

  1. Temperature Calibration Certificate – Annexure-1
  2. Bioreactor Temperature Monitoring Log – Annexure-2
  3. Final Temperature Shutdown Log – Annexure-3

8. References

  • WHO TRS 999 – Biotechnological Manufacturing
  • ICH Q8(R2) – Pharmaceutical Development
  • SOP/BS/050/2025 – Deviation Handling

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Temperature Calibration Certificate

Instrument ID Calibration Date Next Due Date Calibrated By
TRX-07 15/02/2025 15/08/2025 Sunita Reddy

Annexure-2: Bioreactor Temperature Monitoring Log

Date Time Setpoint (°C) Actual Temp (°C) Remarks
04/05/2025 10:00 37.0 37.1 Within range

Annexure-3: Final Temperature Shutdown Log

Batch ID Final Temp (°C) Time of Shutdown Operator
BR-105 36.9 19:30 Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Alarm handling and PID setpoint steps added GMP Compliance
See also  Biosimilars: SOP for Regulatory Compliance for GMOs - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Creams: SOP for Analyzing Preservative Levels in Creams – V 2.0
Next Post: BA-BE Studies: SOP for Contingency Planning for Subject Withdrawal – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version